Art-No.: A-1006
Date: 23-25 November 2016
Price: EUR 380,-
No. | Topic | Summary | Pages |
12682 | Regulatory Requirements for Respiratory Drugs | 0 | 43 |
12683 | Good Development Practices for Inhalation Drug Products | 0 | 0 |
12684 | Development of Modern Nasal Drug Products | 0 | 0 |
12685 | Dose Content Uniformity Test | 0 | 33 |
12686 | Workshop I: Transfer of Inhalation Specific Methods - DCU and APSD | 0 | 17 |
12687 | Particle Size Distribution and Determination | 0 | 44 |
12688 | New Testing for Spacer Devices | 0 | 42 |
12689 | Requirements for Starting Materials for Inhalation and Nasal Drug Products | 0 | 0 |
12690 | Workshop II: Product Characterisation | 0 | 19 |
13744 | Nasal and Nebulizer Testing | 0 | 39 |
14153 | Requirements for Device and Delivery Systems | 0 | 0 |
14154 | Formulation of Biologics for Inhaled and Nasal Drug Products | 0 | 13 |
14155 | Regulatory Strategy for the Global Respiratory Market | 0 | 22 |
14156 | Extractables/Leachables Assessment for MDI and DPI Devices | 0 | 47 |
14157 | Development of Generic and Line Extension Products | 0 | 23 |
14158 | Product Characterisation Studies | 0 | 34 |